ArticleScientific reports2017

JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.

Peng-Peng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.